High doses of biotin in chronic progressive multiple sclerosis: A pilot study.
Antwoord op vraag Louise
Antwoord op vraag Louise
Is er aan de biotine zoals hierboven beschreven te komen"
__________________
LOUISE......
Farmacia Piazza Villari in Turijn. Sturen het naar je toe.
Is er aan de biotine zoals hierboven beschreven te komen"
__________________
LOUISE......
Farmacia Piazza Villari in Turijn. Sturen het naar je toe.
Judy Epstein aan Biotin for Progressive MS
Judy Epstein aan Biotin for Progressive MS
Hi fellow secondaries, I just got this good news. In a nutshell, KEEP AT IT!!! "Dr. Ayman Tourbah from the Université de Reims Champagne-Ardenne (URCA), France gave the final presentation of the session entitled “MD1003 (high doses of biotin) in progressive multiple sclerosis: subgroup analyses of the MS-SPI trial”.1
MD1003 is an experimental drug with pro-myelinotic properties that acts by activating acetyl-CoA carboxylases (ACC1 and ACC2), which are the rate-limiting enzymes in the fatty acids synthesis required for myelin formation. Dr. Tourbah showed results from the MS-SPI trial in patients with progressive MS (primary and secondary), where MD1003 was found to significantly improve MS-related disability and reduce disease progression in comparison to a placebo treatment. This positive clinical effect seemed to be more pronounced in patients with secondary progressive MS. Dr. Tourbah concluded his presentation by stating that MD1003 might be a valuable therapeutic approach for progressive forms of MS.!"
Hi fellow secondaries, I just got this good news. In a nutshell, KEEP AT IT!!! "Dr. Ayman Tourbah from the Université de Reims Champagne-Ardenne (URCA), France gave the final presentation of the session entitled “MD1003 (high doses of biotin) in progressive multiple sclerosis: subgroup analyses of the MS-SPI trial”.1
MD1003 is an experimental drug with pro-myelinotic properties that acts by activating acetyl-CoA carboxylases (ACC1 and ACC2), which are the rate-limiting enzymes in the fatty acids synthesis required for myelin formation. Dr. Tourbah showed results from the MS-SPI trial in patients with progressive MS (primary and secondary), where MD1003 was found to significantly improve MS-related disability and reduce disease progression in comparison to a placebo treatment. This positive clinical effect seemed to be more pronounced in patients with secondary progressive MS. Dr. Tourbah concluded his presentation by stating that MD1003 might be a valuable therapeutic approach for progressive forms of MS.!"
[QUOTE=MiSsty;1028009]Ja ben nu aan de tweede maand begonnen. Het lopen en traplopen gaat beter en heb meer energie.:ogen:
300 stuks van 100 mg per stuk voor plusminus 100 euro.[/QUOTE]
Zo! Dat is niet mis!
Maar je kunt het eens proberen voor een wat milder bedrag.
[url]http://www.bodyenfitshop.nl/vitamines/b ... -strength/[/url]
300 stuks van 100 mg per stuk voor plusminus 100 euro.[/QUOTE]
Zo! Dat is niet mis!
Maar je kunt het eens proberen voor een wat milder bedrag.
[url]http://www.bodyenfitshop.nl/vitamines/b ... -strength/[/url]
Interessant
Interessant
[url]http://www.sciencedirect.com/science/ar ... 111000230X[/url]
[QUOTE] Various neuroimaging findings have been reported in patients with biotinidase deficiency such as cerebral atrophy, ventriculomegaly, widened extracerebral spaces, subdural effusions, caudate involvement, basal ganglia calcifications, cortical abnormalities in the parieto-occipital region and restricted diffusion on DWI.2 and 3 Spinal cord findings have included myelopathy.4 and extensive marked medullary, cervical or thoracic spinal cord demyelination in three Chinese patients.5
[/QUOTE]
[url]http://www.sciencedirect.com/science/ar ... 111000230X[/url]
[QUOTE] Various neuroimaging findings have been reported in patients with biotinidase deficiency such as cerebral atrophy, ventriculomegaly, widened extracerebral spaces, subdural effusions, caudate involvement, basal ganglia calcifications, cortical abnormalities in the parieto-occipital region and restricted diffusion on DWI.2 and 3 Spinal cord findings have included myelopathy.4 and extensive marked medullary, cervical or thoracic spinal cord demyelination in three Chinese patients.5
[/QUOTE]